Taking into consideration the potential anti-cancer effect of FKBP51 inhibition in skin [40] and similarity between atrophic processes in aged skin and skin chronically treated with glucocorticoids [44, 45], the same strategy could be relevant to a safe skin protection against aging. The gene discussed is FKBP4; the disease is cancer.